Genflow Biosciences (GENF) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
No historical short positions

Genflow Biosciences Plc is a UK-based biotechnology company focused on developing gene therapies to combat aging and age-related diseases in humans and dogs. They have R&D facilities in Belgium and a U.S. office in Cambridge, MA. The company's lead compound, GF-1002, utilizes a centenarian variant of the SIRT6 gene to potentially halt or slow the aging process.

Genflow share price launched at 12p in 2022.

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings